AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 JUN 14 - (NewsRx Network) -- Zelnorm[TM] (tegaserod maleate) demonstrated significant improvement of multiple symptoms in female patients with irritable bowel syndrome (IBS) suffering from abdominal pain, discomfort, and constipation, according to a new study.
These data, from a study of more than 1,500 female patients, were presented at the 32nd annual Digestive Disease Week (DDW) meeting in Atlanta, Georgia. Zelnorm currently is under U.S. Food and Drug Administration (FDA) review for the treatment of abdominal pain, discomfort, and constipation in female patients with IBS.
"One of the true unmet needs in medicine today is a safe and effective treatment for IBS, a disease that affects about one-in-five Americans," said Brian Lacy, MD, Assistant Professor of Medicine in the Division of Digestive Diseases at Johns Hopkins Bayview Medical Center, Baltimore, Maryland, and acting director of the Marvin M. Schuster Center for Digestive and Motility Disorders. "These findings suggest a major advance in treating IBS because the data demonstrate that the majority of patients treated with Zelnorm experienced relief within the first week of treatment."
In the ...
Source: HighBeam Research, Tegaserod Maleate Effective For Abdominal Pain,...